Bausch + Lomb Said to Be Eying an IPO Sometime in FY12
Tweet Send to a Friend
Eye care giant Bausch + Lomb Inc. may be looking at an IPO before the end of 2012.
According to the WSJ, Bausch looked to bulk-up via acquisitions, though its been part of a longer-term plan to take the company public.
Though it expected to file papers over the summer, Bausch first wanted to absorb the recent $600 million acquisition of ISTA Pharmaceuticals.
Bausch went private in 2007 for $3.7 billion. It's not clear what an IPO might bring, but Bausch's revs in 2010 were $2.8 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
According to the WSJ, Bausch looked to bulk-up via acquisitions, though its been part of a longer-term plan to take the company public.
Though it expected to file papers over the summer, Bausch first wanted to absorb the recent $600 million acquisition of ISTA Pharmaceuticals.
Bausch went private in 2007 for $3.7 billion. It's not clear what an IPO might bring, but Bausch's revs in 2010 were $2.8 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Sprint (S) to Raise Offer for Clearwire (CLWR) - DJ
- Royalty Pharma to Raise Bid for Elan (ELN) - CNBC Faber
- GDC Technology (GDCT) Files $75M IPO
Create E-mail Alert Related Categories
IPOs, RumorsRelated Entities
Bausch + Lomb/ISTA Pharmaceuticals
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
